Fecal dimeric M2-pyruvate kinase (tumor
โ
Jinny Jeffery; Stephen J. Lewis; Ruth M. Ayling
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 109 KB
Background: Fecal inflammatory markers have been shown to be useful as noninvasive screening tools to differentiate patients with functional from organic bowel pathology. Of these markers calprotectin has been the most intensively studied. More recently, the dimeric isoform of M2-pyruvate kinase (tu